Fig. 1From: ESR1 PvuII polymorphism: from risk factor to prognostic and predictive factor of the success of primary systemic therapy in advanced breast cancerThe result of Sanger sequencing showing a different type of ESR1 PvuII Polymorphism. The red circle show the base change (Y is bioinformatics code for the presence of T or C)Back to article page